Antitumour activity of a chimeric antibody against the leucocyte antigen CD48

Cancer Immunology Immunotherapy

Volumn 48, Issue 10, 2000, Pages 595-602

  Sun, Haiping ^a   Biggs, James C ^a   Smith, Glenn M ^a  

^a CRC for Biopharmaceutical Research   (Australia)

Author keywords

CD48; Chimeric antibody; Immunotherapy; Leukaemia; Lymphoma

Indexed keywords

CD48 ANTIGEN; CHIMERIC ANTIBODY; IMMUNOGLOBULIN G2A; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN LIGHT CHAIN; MONOCLONAL ANTIBODY MHULYM3; UNCLASSIFIED DRUG;

ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER IMMUNOTHERAPY; CONTROLLED STUDY; EFFECTOR CELL; EXPRESSION VECTOR; GENE AMPLIFICATION; HUMAN; HUMAN CELL; IMMUNOGENICITY; IMMUNOGLOBULIN CONSTANT REGION; IMMUNOGLOBULIN VARIABLE REGION; LEUKEMIA; LYMPHOMA; MONONUCLEAR CELL; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, NEOPLASM; ANTIGENS, CD; ANTINEOPLASTIC AGENTS; BASE SEQUENCE; CLONING, MOLECULAR; GENES, IMMUNOGLOBULIN; HUMANS; IMMUNITY, CELLULAR; IMMUNOGLOBULIN VARIABLE REGION; IMMUNOTHERAPY; LYMPHOMA; MICE; MOLECULAR SEQUENCE DATA; RECOMBINANT FUSION PROTEINS;

EID: 0033986782     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00006678     Document Type: Article

References (31)

1. 1. Arulanandam ARN, Moingeon P, Concino MF, Recny MA, Kato K, Yagita H, Koyasu S, Reinherz EL (1993) A soluble multimeric recombinant CD2 protein identifies CD48 as a low affinity ligand for human CD2: divergence of CD2 ligands during the evolution of humans and mice. J Exp Med 177:1439
2. 2. Barrett AJ, Horowitz MM (1992) Transplants in ALL. Bone Marrow Transplant 10 [Suppl]:30-36
3. 3. Bruggemann M, Williams GT, Bindon CI, Clark MR, Walker MR, Jefferis R, Waldmann H, Neuberger MS (1987) Comparison of the effector functions of human immunogloblins using a matched set of chimeric antibodies. J Exp Med 166:1351
4. 4. Cheson BD (1994) Chronic lymophocytic leukemia and hairy-cell leukemia. Curr Opin Hematol 1:268-277
5. 5. Chomczynski P, Sacchi N (1987) Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159
6. 6. Dickman S (1998) Antibodies stage a comeback in cancer treatment. Science 280:1196-1197
7. 7. Dyer MJS, Hale G, Hayhoe FGJ, Waldmann H (1989) Effects of CAMPATH-1 antibodies in vivo in patients with lymphoid malignancies: Influence of antibody isotype. Blood 73:1431
8. 8. Dyer MJS, Hale G, Marcus R, Waldmann H (1990) Remission induced in patients with lymphoid malignancies using unconjugated CAMPATH-1 monoclonal antibodies. Leukemia Lymphoma 2:179
9. 9. Genentech Inc (1999) www: gene.com
10. 10. Greenaway S, Henniker AJ, Walsh M, Bradstock KF (1994) A pilot clinical trial of two murine monoclonal antibodies fixing human complement in patients with chronic lymphatic leukaemia. Leukemia Lymphoma 13:323-331
11. 11. Greenwood J, Clark M (1993) Effector functions of matched sets of recombinant human IgG subclass antibodies. In Clark M (ed) Antibody effector functions, section II. Protein engineering of antibody molecules for prophylactic and therapeutic applications in man. Academic Titles, Nottingham, p85
12. 12. Hadam MR (1989) N10 Cluster report: CD48. NK-and non-lineage antigens. In: Fourth international workshop and conference on human leucocyte differentiation antigens, P661
13. 13. Haynes BF, Heinly CS (1995) Early human T cell development: analysis of the human thymus at the time of initial entry of hematopoietic stem cells into the fetal thymic microenvironment. J Exp Med 181:1445-1458
14. 14. Henniker AJ, Bradstock KF, Grimsley P, Atkinson MK (1990) A novel non-lineage antigen on human leucocytes: characterisation with two CD-48 monoclonal antibodies. Dis Markers 8:179
15. 15. Herlyn D, Koprowski H (1982) IgG2a monoclonal antibodies inhibit human tumour growth through interaction with effector cells. J Biol Chem 79:4761
16. 16. Jumhans RP, Waldman TA, Landofi NF, Avalovic NM, Schneider WP, Queen C (1992) Anti-TAC-H, a humanised antibody to the interleukin-2 receptor with new features for immunotherapy in malignant and immune disorders. Cancer Res 50:1495-1502
17. 17. Kato K, Koyanagi M, Okada H, Takanashi T, Wong YW, Williams AF, Okumura K, Yagita H. (1992) CD48 is a counter-receptor for mouse CD2 and is involved in T cell activation. J Exp Med 176:1241
18. 18. Korinek V, Stefanova I, Angelisova P, Hilgert I, Horejsi V (1991) The human leucocyte antigen CD48 (MEM-102) is closely related to the activation marker Blast-1. Immunogenetics 33:108
19. 19. Longo DL (1994) Non-Hodgkin's lymphoma. Curr Opin Hematol 1:295-302
20. 20. Marchuk D, Drumm M, Saulino A, Collins FS (1991) Construction of T-vectors, a rapid and general system for direct cloning of unmodified PCR products. Nucleic Acids Res 19:1154
21. 21. Morelock MM, Rothlein R, Bright SM, Robinson MK, Graham ET, Sabo J, Owens R, King DJ, Norris SH, Scher DS, Wright JL, Adair JR (1994) Isotype choice for chimeric antibodies affects binding properties. J Biol Chem 269:13048-13055
22. 22. Mount PF, Sutton VR, Wenjun L, Burgess J, McKenzie IFC, Pietersz GA, Trapani JA (1994) Chimeric anti-colon cancer antibody c30.6 inhibits the growth of human colorectal cancer xenografts in scid/scid mice. Cancer Res 54:6160-6166
23. 23. Presky DH, Low MG and Shevach EM (1990) Role of phosphatidylinositol anchored proteins in T cell activation. J Immunol 144:860
24. 24. Robinson PJ (1991) Phosphatidylinositol membrane anchors and T cell activation. Immunol Today 12:35-41
25. 25. Sandrin MS, Mouhtouris E, Vaughan HA, Warren HS, Parish CR (1993) CD48 is a low affinity ligand for human CD2. J Immunol 151:4606
26. 26. Shin SU (1991) Chimeric antibody: potential applications for drug delivery and immunotherapy. Biotherapy 3:43
27. 27. Staunton DE, Thorley-Lawson DA (1987) Molecular cloning of the lymphocyte activation marker Blast-1. EMBO J 6:3695
28. 28. Sun HP, Norris BJ, Atkinson K, Biggs JC, Smith GM (1998) Preclinical antitumour activity of an antibody against the leukocyte antigen CD48. Clin Cancer Res 4:895-900
29. 29. Vaughan HA, Thompson CH, Sparrow RL, McKenzie IFC (1983) HuLy-m3 - a human leucocyte antigen. Transplantation 36:446
30. 30. Vaughan HA, Thompson CH, Sparrow RL, McKenzie IFC (1983) HuLy-m3 - a human leukocyte antigen. Transplantation 36:446
31. 31. Vaughan HA, Henning MM, Purcell DFJ, McKenzie IFC, Sandrin MS (1991) The isolation of cDNA clones for CD48. Immunogenetics 33:113